Xenetic Biosciences (XBIO) Revenue & Revenue Breakdown
Xenetic Biosciences Revenue Highlights
Latest Revenue (Y)
$2.54M
Latest Revenue (Q)
$614.24K
Main Segment (Y)
Royalty Revenue
Main Geography (Y)
Royalty Revenue
Xenetic Biosciences Revenue by Period
Xenetic Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.54M | 48.80% |
| 2022-12-31 | $1.71M | 47.06% |
| 2021-12-31 | $1.16M | 165.64% |
| 2020-12-31 | $436.94K | 2460.31% |
| 2019-12-31 | $17.07K | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2017-12-31 | $7.58M | 152.83% |
| 2016-12-31 | $3.00M | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $1.00M | 240.60% |
| 2012-12-31 | $293.60K | - |
Xenetic Biosciences generated $2.54M in revenue during NA 2023, up 48.80% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Xenetic Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $614.24K | -15.44% |
| 2024-06-30 | $726.40K | 42.20% |
| 2024-03-31 | $510.82K | -23.98% |
| 2023-12-31 | $671.96K | 9.95% |
| 2023-09-30 | $611.17K | -6.12% |
| 2023-06-30 | $651.00K | 7.45% |
| 2023-03-31 | $605.84K | 24.41% |
| 2022-12-31 | $486.97K | 17.56% |
| 2022-09-30 | $414.25K | -0.59% |
| 2022-06-30 | $416.71K | 7.13% |
| 2022-03-31 | $388.99K | 16.95% |
| 2021-12-31 | $332.60K | -4.77% |
| 2021-09-30 | $349.27K | 21.44% |
| 2021-06-30 | $287.60K | 50.41% |
| 2021-03-31 | $191.22K | 26.36% |
| 2020-12-31 | $151.33K | 30.53% |
| 2020-09-30 | $115.93K | 2.66% |
| 2020-06-30 | $112.93K | 98.99% |
| 2020-03-31 | $56.75K | 232.53% |
| 2019-12-31 | $17.07K | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-12-31 | $7.50M | 8723.53% |
| 2017-09-30 | $85.00K | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $3.00M | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-11-30 | $2.17K | -126.98% |
| 2013-08-31 | $-8.04K | -120.40% |
| 2013-05-31 | $39.41K | 21.05% |
| 2013-02-28 | $32.56K | -1.23% |
| 2012-11-30 | $32.96K | 23.74% |
| 2012-08-31 | $26.64K | -26.87% |
| 2012-05-31 | $36.43K | 1.29% |
| 2012-02-29 | $35.97K | 161.60% |
| 2011-11-30 | $13.75K | - |
Xenetic Biosciences generated $614.24K in revenue during Q3 2024, up -15.44% compared to the previous quarter, and up 94.35% compared to the same period a year ago.
Xenetic Biosciences Revenue Breakdown
Xenetic Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 20 |
|---|---|
| Royalty Revenue | $437.00K |
Xenetic Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 20: Royalty Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
|---|---|---|---|---|---|---|---|---|
| Royalty Revenue | $300.00K | $300.00K | $151.00K | $17.00K | - | - | - | - |
| RoyaltyRevenueMember | - | - | $200.00K | $116.00K | $113.00K | $57.00K | - | - |
Xenetic Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: Royalty Revenue (100.00%).
Xenetic Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 |
|---|---|
| Royalty Revenue | $437.00K |
Xenetic Biosciences's latest annual revenue breakdown by geography, as of Dec 20: Royalty Revenue (100.00%).
Quarterly Revenue by Country
| Country | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
|---|---|---|---|---|---|---|---|---|
| Royalty Revenue | $300.00K | $300.00K | $151.00K | $17.00K | - | - | - | - |
| RoyaltyRevenueMember | - | - | $200.00K | $116.00K | $113.00K | $57.00K | - | - |
Xenetic Biosciences's latest quarterly revenue breakdown by geography, as of Sep 21: Royalty Revenue (100.00%).
Xenetic Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| YS | LakeShore Biopharma | $687.20M | $164.98M |
| TNXP | Tonix Pharmaceuticals | $7.77M | $2.82M |
| XBIO | Xenetic Biosciences | $2.54M | $614.24K |
| PALI | Palisade Bio | $250.00K | - |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| CYTO | Altamira Therapeutics | - | $52.73K |
| ZURA | Zura Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| ATNF | 180 Life Sciences | - | - |
| DRUG | Bright Minds Biosciences | - | - |
| GOVX | GeoVax Labs | - | $300.68K |
| PHIO | Phio Pharmaceuticals | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| IMMX | Immix Biopharma | - | - |
| ONCR | Oncorus | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| LABP | Landos Biopharma | - | - |
| ENVB | Enveric Biosciences | - | - |